Overcoming the roadblocks in hepatitis C virus infection

Journal of Hepatology

Volumn 61, Issue 1, 2014, Pages S1-S2

  Baumert, Thomas F ^a,b,c   Zeuzem, Stefan ^d  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LEDIPASVIR PLUS SOFOSBUVIR; OMBITASVIR; RIBAVIRIN; SOFOSBUVIR; VIRUS VACCINE;

DECOMPENSATED LIVER CIRRHOSIS; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIFE CYCLE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; TREATMENT RESPONSE; ADAPTIVE IMMUNITY; ANIMAL; DISEASE MODEL; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; IMMUNOLOGY; INNATE IMMUNITY; PREVALENCE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, INNATE; PREVALENCE; VIRAL VACCINES;

EID: 84913589870     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.034     Document Type: Editorial

References (2)

1. R.T. Chung, and T.F. Baumert Curing chronic hepatitis C - The arc of a medical triumph N Engl J Med 370 2014 1576 1578
2. C.M. Lange, I.M. Jacobson, C.M. Rice, and S. Zeuzem Emerging therapies for the treatment of hepatitis C EMBO Mol Med 6 2014 4 15